Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | AR | P10275 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19951506 | 1.00 | CA1 (0.43) | CA1CA2CA9KDM4EALDH1A1 | |
| SCHEMBL202567 | 0.97 | CA1 (0.45) | CA1CA2CA9KDM4EALDH1A1 | |
| SCHEMBL5360236 | 0.89 | AR (0.43) | CA1CA2CA9KDM4EALDH1A1 | |
| Ethylene Glycol SCHEMBL7535155 | 0.88 | CA1 (0.39) | CA1CA2CA9KDM4EALDH1A1 | |
| SCHEMBL5324603 | 0.86 | AR (0.44) | CA1CA2CA9KDM4EALDH1A1 | |
| SCHEMBL7535158 | 0.85 | CA1 (0.41) | CA1CA2CA9KDM4EALDH1A1 | |
| SCHEMBL8736197 | 0.84 | HSD17B10 (0.52) | CA1CA2CA9KDM4EALDH1A1 | |
| SCHEMBL9447829 | 0.82 | CA1 (0.39) | CA1CA2CA9KDM4EALDH1A1 | |
| SCHEMBL9447834 | 0.82 | CA1 (0.39) | CA1CA2CA9KDM4EALDH1A1 | |
| Di(Hydroxyethyl)Ether SCHEMBL9447831 | 0.82 | TSHR (0.48) | CA1CA2CA9KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8933294-B2 | Absorbent product comprising a cationic modified starch | THE PROCTER & GAMBLE COMPANY (US) | 2015-01-13 | — | — | US | claimed |
| CN-107312102-B | Modified polysaccharides | 玉米产品开发公司 | 2021-11-23 | — | — | CN | disclosed |
| US-10143643-B2 | Modified polysaccharides | CORN PRODUCTS DEVELOPMENT, INC. (US) | 2018-12-04 | — | — | US | disclosed |
| EP-3239180-B1 | MODIFIED POLYSACCHARIDES | CORN PRODUCTS DEV INC (BR) | 2018-11-28 | — | — | EP | disclosed |
| US-20180071196-A1 | COMPOSITIONS COMPRISING MODIFIED POLYSACCHARIDES AND USES THEREOF | CORN PRODUCTS DEVELOPMENT, INC. (BR) | 2018-03-15 | — | — | US | disclosed |
| US-20180071195-A1 | MODIFIED POLYSACCHARIDES | CORN PRODUCTS DEVELOPMENT, INC. (BR) | 2018-03-15 | — | — | US | disclosed |
| US-9820928-B1 | Modified polysaccharides | CORN PRODUCTS DEVELOPMENT, INC. (BR) | 2017-11-21 | — | — | US | disclosed |
| US-20170312213-A1 | MODIFIED POLYSACCHARIDES | CORN PRODUCTS DEVELOPMENT, INC. (BR) | 2017-11-02 | — | — | US | disclosed |
| EP-3239180-A1 | MODIFIED POLYSACCHARIDES | Corn Products Development, Inc. (BR) | 2017-11-01 | — | — | EP | disclosed |
| US-8933294-B2 | Absorbent product comprising a cationic modified starch | THE PROCTER & GAMBLE COMPANY (US) | 2015-01-13 | — | — | US | disclosed |
| EP-2123310-B1 | Absorbent product comprising a cationic modified starch | PROCTER & GAMBLE (US) | 2012-12-12 | — | — | EP | disclosed |
| US-20110306492-A1 | ABSORBENT PRODUCT COMPRISING A MIXTURE OF A CATIONIC POLYSACCHARIDE AND A HYDROPHILIC CARRIER MATRIX | PROCTER & GAMBLE COMPANY, THE | 2011-12-15 | — | — | US | disclosed |
| EP-2394669-A1 | Absorbent product comprising a cationic polysaccharide in a hydrophilic carrier matrix | The Procter & Gamble Company (US) | 2011-12-14 | — | — | EP | disclosed |
| EP-2123310-A1 | Absorbent product comprising a cationic modified starch | The Procter and Gamble Company (US) | 2009-11-25 | — | — | EP | disclosed |
| US-5780616-A | Cationic polymer | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-14 | — | — | US | disclosed |
| US-4020271-A | SANITARY NAPKINS AND TAMPONS | PERSONAL PRODUCTS COMPANY (US) | 1977-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180071195-A1 | MODIFIED POLYSACCHARIDES | ALG1, HDAC1, CSGALNACT1 | CA1 821/4885CA2 659/4885CA9 220/4885 |
| US-20170312213-A1 | MODIFIED POLYSACCHARIDES | ALG1, HDAC1, CSGALNACT1 | CA1 821/4885CA2 659/4885CA9 220/4885 |
| US-20180071196-A1 | COMPOSITIONS COMPRISING MODIFIED POLYSACCHARIDES AND USES THEREOF | ALG1, CD44, CSGALNACT1 | CA1 531/4885CA2 561/4885CA9 129/4885 |
| US-10143643-B2 | Modified polysaccharides | ALG1, HDAC1, CSGALNACT1 | CA1 821/4885CA2 659/4885CA9 220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.